Cite
AZ-4217: a high potency BACE inhibitor displaying acute central efficacy in different in vivo models and reduced amyloid deposition in Tg2576 mice
MLA
Britt-Marie Swahn, et al. “AZ-4217: A High Potency BACE Inhibitor Displaying Acute Central Efficacy in Different in Vivo Models and Reduced Amyloid Deposition in Tg2576 Mice.” The Journal of Neuroscience : The Official Journal of the Society for Neuroscience, vol. 33, no. 24, June 2013. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5c92f198c1a255d3d4f750e538efd83e&authtype=sso&custid=ns315887.
APA
Britt-Marie Swahn, Sveinn Briem, Susanna Eketjäll, Fredrik Jeppsson, Kristina Eliason, Juliette Janson, Alexander Svanhagen, Camilla Niva, Anna-Lena Berg, Sofia Karlström, Karin Kolmodin, Susanne Gustavsson, Johanna Fälting, Ann-Cathrin Radesäter, & Paulina Appelkvist. (2013). AZ-4217: a high potency BACE inhibitor displaying acute central efficacy in different in vivo models and reduced amyloid deposition in Tg2576 mice. The Journal of Neuroscience : The Official Journal of the Society for Neuroscience, 33(24).
Chicago
Britt-Marie Swahn, Sveinn Briem, Susanna Eketjäll, Fredrik Jeppsson, Kristina Eliason, Juliette Janson, Alexander Svanhagen, et al. 2013. “AZ-4217: A High Potency BACE Inhibitor Displaying Acute Central Efficacy in Different in Vivo Models and Reduced Amyloid Deposition in Tg2576 Mice.” The Journal of Neuroscience : The Official Journal of the Society for Neuroscience 33 (24). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5c92f198c1a255d3d4f750e538efd83e&authtype=sso&custid=ns315887.